Back to Blog
CAFC-PTOOctober 15, 2026·26-1801·Dismissed.

Alamar Biosciences, Inc. v. Olink Proteomics AB

Patent Trial and Appeal Board

Holding

On the parties' agreement, the Federal Circuit dismissed the appeal from the PTAB's decision in IPR2024-01353 under Fed. R. App. P. 42(b). Each side bears its own costs, and the order issued as the mandate.

Why It Matters

The appeal ends without any ruling on the merits, so the order offers no guidance. What happens to the underlying IPR outcome is not addressed in the order.

Full Summary

Alamar Biosciences, Inc. v. Olink Proteomics AB On the parties' agreement, the Federal Circuit dismissed the appeal from the PTAB's decision in IPR2024-01353 under Fed. R. App. P. 42(b). Each side bears its own costs, and the order issued as the mandate. The appeal ends without any ruling on the merits, so the order offers no guidance. What happens to the underlying IPR outcome is not addressed in the order. Dismissed. Alamar Biosciences appealed from the PTAB in IPR2024-01353; Olink Proteomics AB is the appellee. The parties agreed to dismissal, and the court dismissed the proceeding under Fed. R. App. P. 42(b). Each side shall bear its own costs. The order issued as the mandate on October 15, 2026. The order does not identify the patent, claims, or issues and decides nothing on the merits. standing / jurisdiction non-precedential standing / jurisdiction non-precedential standing / jurisdiction

Key Points

  • Alamar Biosciences appealed from the PTAB in IPR2024-01353; Olink Proteomics AB is the appellee.
  • The parties agreed to dismissal, and the court dismissed the proceeding under Fed. R. App. P. 42(b).
  • Each side shall bear its own costs.
  • The order issued as the mandate on October 15, 2026.
  • The order does not identify the patent, claims, or issues and decides nothing on the merits.
standing / jurisdictionnon-precedential

How this summary was made: Drafted with AI from the court's opinion or order; before publishing, code checked that the quotation and the citations it gives appear in that document. Editorial policy

More on this topic

New to District court litigation? Start with PTAB vs. District Court: Where to Challenge a Patent’s Validity